ArticleBMC cardiovascular disorders2022

Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.

Qun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.